BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alqaraghuli HGJ, Kashanian S, Rafipour R. A Review on Targeting Nanoparticles for Breast Cancer. Curr Pharm Biotechnol 2019;20:1087-107. [PMID: 31364513 DOI: 10.2174/1389201020666190731130001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Ayana G, Ryu J, Choe SW. Ultrasound-Responsive Nanocarriers for Breast Cancer Chemotherapy. Micromachines (Basel) 2022;13:1508. [PMID: 36144131 DOI: 10.3390/mi13091508] [Reference Citation Analysis]
2 Ning WJ, Liu X, Zeng HY, An ZQ, Luo WX, Xia NS. Recent progress in antibody-based therapeutics for triple-negative breast cancer. Expert Opin Drug Deliv 2022. [PMID: 35738312 DOI: 10.1080/17425247.2022.2093853] [Reference Citation Analysis]
3 Fraguas-sánchez AI, Lozza I, Torres-suárez AI. Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic. Cancers 2022;14:1198. [DOI: 10.3390/cancers14051198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
4 Salem HF, Gamal A, Saeed H, Tulbah AS. The Impact of Improving Dermal Permeation on the Efficacy and Targeting of Liposome Nanoparticles as a Potential Treatment for Breast Cancer. Pharmaceutics 2021;13:1633. [PMID: 34683926 DOI: 10.3390/pharmaceutics13101633] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Baker A, Khan MS, Iqbal MZ, Khan MS. Tumor-targeted Drug Delivery by Nanocomposites. Curr Drug Metab 2020;21:599-613. [PMID: 32433002 DOI: 10.2174/1389200221666200520092333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Canese R, Vurro F, Marzola P. Iron Oxide Nanoparticles as Theranostic Agents in Cancer Immunotherapy. Nanomaterials (Basel) 2021;11:1950. [PMID: 34443781 DOI: 10.3390/nano11081950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Qian Y, Zhang J, Xu R, Li Q, Shen Q, Zhu G. Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment. Int J Biol Macromol 2021;183:2215-26. [PMID: 34097964 DOI: 10.1016/j.ijbiomac.2021.05.204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zhang X, Gao Q, Zhuang Q, Zhang L, Wang S, Du L, Yuan W, Wang C, Tian Q, Yu H, Zhao Y, Liu Y. A dual-functional nanovehicle with fluorescent tracking and its targeted killing effects on hepatocellular carcinoma cells. RSC Adv 2021;11:10986-95. [PMID: 35423573 DOI: 10.1039/d0ra10486h] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Pan X, Su N, Li J, Huang H, Wu Z, Sha K, Chen J, Wu Z, Qi X. Tetralysine modified H-chain apoferritin mediated nucleus delivery of chemotherapy drugs synchronized with passive diffusion. Journal of Drug Delivery Science and Technology 2021;61:102132. [DOI: 10.1016/j.jddst.2020.102132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jahan S, Karim ME, Chowdhury EH. Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics. Biomedicines 2021;9:114. [PMID: 33530291 DOI: 10.3390/biomedicines9020114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
11 Karabasz A, Bzowska M, Szczepanowicz K. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature. Int J Nanomedicine 2020;15:8673-96. [PMID: 33192061 DOI: 10.2147/IJN.S231477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
12 Przanowski P, Lou S, Tihagam RD, Mondal T, Conlan C, Shivange G, Saltani I, Singh C, Xing K, Morris BB, Mayo MW, Teixeira L, Lehmann-Che J, Tushir-Singh J, Bhatnagar S. Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer. Cancer Res 2020;80:4791-804. [PMID: 32855208 DOI: 10.1158/0008-5472.CAN-20-1459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]